LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=mc12e27d324b9d1a854d4ec2f9a9593e3

OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Identify when surgery, chemo, and/or radiation should be used for treatment, (2) Recognize new pathologic test that can provide prognostic indications for treatment decisions, (3) Identify new drugs and/or treatment modalities as they become available to treat cancer.  This tumor board is designed to review existing cases and apply the most current evidence-based knowledge and guidelines to establish treatment plans for improved patient outcomes. With the changing landscape of healthcare, there is a need for physicians to continuously review surgical cases to be sure the patient is being provided with the NCCN guidelines, appropriate care and are aware of the most recent treatment options available for best care.  

FACULTY DISCLOSURE:  Hitesh Singh, MD, and Rudranath Talukdar do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.  

PLANNERS DISCLOSURES: Hitesh Singh, MD, Rudranath Talukdar, and Christy Hale, CTR, RHIT do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

For information please contact Christy Hale at Christy.Hale@BSWHealth.org